265 related articles for article (PubMed ID: 17934195)
21. Nicotine increases ethanol preference but decreases locomotor activity during the initial stages of chronic ethanol withdrawal.
Lallemand F; Ward RJ; De Witte P
Alcohol Alcohol; 2007; 42(3):207-18. PubMed ID: 17526630
[TBL] [Abstract][Full Text] [Related]
22. Leuprolide: a luteinizing hormone releasing hormone agonist attenuates ethanol withdrawal syndrome and ethanol-induced locomotor sensitization in mice.
Umathe SN; Bhutada PS; Dixit PV; Jain NS
Neuropeptides; 2008 Jun; 42(3):345-53. PubMed ID: 18280564
[TBL] [Abstract][Full Text] [Related]
23. Studies on the effects of certain 5-HT-3 receptor antagonists on ethanol preference and withdrawal seizures in the rat.
Kostowski W; Bisaga A; Jankowska E; Krzaścik P
Pol J Pharmacol; 1994; 46(3):133-7. PubMed ID: 8000444
[TBL] [Abstract][Full Text] [Related]
24. The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice.
Verleye M; Heulard I; Gillardin JM
Alcohol; 2009 May; 43(3):197-206. PubMed ID: 19393860
[TBL] [Abstract][Full Text] [Related]
25. Development of pregnancy in rats treated with Hypericum perforatum.
Borges LV; do Carmo Cancino JC; Peters VM; Las Casas L; de Oliveira Guerra M
Phytother Res; 2005 Oct; 19(10):885-7. PubMed ID: 16261520
[TBL] [Abstract][Full Text] [Related]
26. Effects of an alkaloid-rich extract from Mitragyna speciosa leaves and fluoxetine on sleep profiles, EEG spectral frequency and ethanol withdrawal symptoms in rats.
Cheaha D; Keawpradub N; Sawangjaroen K; Phukpattaranont P; Kumarnsit E
Phytomedicine; 2015 Oct; 22(11):1000-8. PubMed ID: 26407942
[TBL] [Abstract][Full Text] [Related]
27. Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats.
Zhao Y; Weiss F; Zorrilla EP
Alcohol Clin Exp Res; 2007 Sep; 31(9):1505-15. PubMed ID: 17760785
[TBL] [Abstract][Full Text] [Related]
28. Long-term administration of tianeptine in depressed patients after alcohol withdrawal.
Malka R; Lôo H; Ganry H; Souche A; Marey C; Kamoun A
Br J Psychiatry Suppl; 1992 Feb; (15):66-71. PubMed ID: 1389025
[TBL] [Abstract][Full Text] [Related]
29. Dextromethorphan attenuates ethanol withdrawal syndrome in rats.
Erden BF; Ozdemirci S; Yildiran G; Utkan T; Gacar N; Ulak G
Pharmacol Biochem Behav; 1999 Mar; 62(3):537-41. PubMed ID: 10080248
[TBL] [Abstract][Full Text] [Related]
30. Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism.
De Vry J; Maurel S; Schreiber R; de Beun R; Jentzsch KR
Eur Neuropsychopharmacol; 1999 Dec; 9(6):461-8. PubMed ID: 10625112
[TBL] [Abstract][Full Text] [Related]
31. Effect of acetyl-L-carnitine on ethanol consumption and alcohol abstinence syndrome in rats.
Mangano NG; Clementi G; Costantino G; Calvani M; Matera M
Drugs Exp Clin Res; 2000; 26(1):7-12. PubMed ID: 10761531
[TBL] [Abstract][Full Text] [Related]
32. Serotonergic mediation effects of St John's wort in rats subjected to swim stress.
Bano S; Dawood S
Pak J Pharm Sci; 2008 Jan; 21(1):63-9. PubMed ID: 18166522
[TBL] [Abstract][Full Text] [Related]
33. The open field: a simple method to show ethanol withdrawal symptoms.
Capaz FR; Vanconcellos LE; De Moraes S; Neto JP
Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):228-36. PubMed ID: 7197142
[TBL] [Abstract][Full Text] [Related]
34. Effects of chronic ethanol administration and ethanol withdrawal on cyclic guanosine 3',5'-monophosphate (cGMP) levels in the rat brain.
Uzbay IT; Celik T; Aydin A; Kayir H; Tokgöz S; Bilgi C
Drug Alcohol Depend; 2004 Apr; 74(1):55-9. PubMed ID: 15072807
[TBL] [Abstract][Full Text] [Related]
35. Effects of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons and neuroleptic or bromocriptine treatment on ethanol withdrawal syndrome in rats.
Trzaskowska E; Puciłowski O; Kostowski W; Bidziński A
Pol J Pharmacol Pharm; 1983; 35(5):339-49. PubMed ID: 6141554
[TBL] [Abstract][Full Text] [Related]
36. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats.
Uzbay IT; Akarsu ES; Kayaalp SO
Pharmacol Biochem Behav; 1994 Dec; 49(4):969-74. PubMed ID: 7886115
[TBL] [Abstract][Full Text] [Related]
37. [Guidelines for the drug therapy of alcoholism].
Gessa GL
Recenti Prog Med; 1990 Mar; 81(3):171-5. PubMed ID: 2359869
[TBL] [Abstract][Full Text] [Related]
38. Characterization of fluoxetine effects on ethanol withdrawal-induced cortical hyperexcitability by EEG spectral power in rats.
Cheaha D; Sawangjaroen K; Kumarnsit E
Neuropharmacology; 2014 Feb; 77():49-56. PubMed ID: 24076335
[TBL] [Abstract][Full Text] [Related]
39. Effects of Hypericum perforatum extraction on alcohol intake in Marchigian Sardinian alcohol-preferring rats.
Perfumi M; Ciccocioppo R; Angeletti S; Cucculelli M; Massi M
Alcohol Alcohol; 1999; 34(5):690-8. PubMed ID: 10528811
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
Brattström A
Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
